About ViaLase
ViaLase is a company based in Newport Beach (United States) founded in 2018. ViaLase has raised $45.18 million across 2 funding rounds from investors including Falcon-Vision, Venture Investors and Arboretum Ventures. ViaLase offers products and services including ViaLase Laser System and FLigHT Procedure. ViaLase operates in a competitive market with competitors including BELKIN Vision, ELIOS Vision, Radiance Therapeutics and EyeLight, among others.
- Headquarter Newport Beach, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vialase, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$45.18 M (USD)
in 2 rounds
-
Latest Funding Round
$45.18 M (USD), Series C
Mar 25, 2024
-
Investors
Falcon-Vision
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ViaLase
ViaLase offers a comprehensive portfolio of products and services, including ViaLase Laser System and FLigHT Procedure.
Noninvasive laser for creating apertures in trabecular meshwork to treat glaucoma.
Noninvasive glaucoma intervention without surgery or incisions.
People of ViaLase
Unlock access to complete
Funding Insights of ViaLase
ViaLase has successfully raised a total of $45.18M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $45.18 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ViaLase
ViaLase has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Falcon-Vision, Venture Investors and Arboretum Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Industrial machinery is manufactured and distributed by Falcon-Vision since 1996.
|
Locked | Locked | Locked |
Investor details for ViaLase
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ViaLase
Investment portfolio details for ViaLase
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ViaLase
Detailed financials for ViaLase
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vialase Comparisons
Peer comparison for ViaLase
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ViaLase
ViaLase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BELKIN Vision, ELIOS Vision, Radiance Therapeutics and EyeLight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laser device for glaucoma treatment developed by BELKIN Vision.
|
|
| Locked | Locked | Locked |
Excimer laser technology is applied to develop glaucoma therapy devices.
|
|
| Locked | Locked | Locked |
Beta ophthalmic applicator for glaucoma surgery is developed.
|
|
| Locked | Locked | Locked |
Develops patented treatment methods for glaucoma.
|
Detailed competitors of ViaLase
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vialase
Complete news archive for ViaLase
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ViaLase
ViaLase was founded in 2018 and raised its 1st funding round 6 years after it was founded.
ViaLase is headquartered in Newport Beach, United States. It is registered at Newport Beach, California, United States.
ViaLase is a funded company, having raised a total of $45.18M across 2 funding rounds to date.
The company was founded in 2018 and is headquartered in Newport Beach, United States. Operations center on the medical device sector, specifically ophthalmology, where image-guided femtosecond laser systems are developed for glaucoma procedures. These devices incorporate imaging technology to assist surgical interventions. Focus remains on advancing treatments for glaucoma patients through precise, non-invasive methods in a clinical setting.
ViaLase's top competitors include ELIOS Vision, BELKIN Vision and Radiance Therapeutics.
ViaLase offers ViaLase Laser System and FLigHT Procedure.
ViaLase has 3 investors. Key investors include Falcon-Vision, Venture Investors, and Arboretum Ventures.